Marcela Maus: Closing plenary to explore the future of CAR T-Cell therapy in solid tumors
Mediamedic posted on LinkedIn:
”Closing Plenary: The Future of CAR T-Cell Therapy in Solid Tumors
The final plenary of Tandem Meetings 2025, chaired by Dr. Marcela Maus (Massachusetts General Hospital Cancer Center, Harvard Medical School), explored the next frontier in cellular immunotherapy – expanding CAR T-cell therapy from hematologic cancers to solid tumors.
Speakers Dr. Saul Priceman (USC) and Dr. Julia Carnevale (UCSF) presented cutting-edge research on tumor microenvironment modulation, CRISPR-based functional genomics, and next-generation T-cell engineering aimed at overcoming T-cell exhaustion and antigen heterogeneity.
“This closing plenary offers an exciting glimpse into the future of cellular therapeutics,” said Dr. Maus. “We are united in improving the patient experience and curing disease by leveraging cells as medicine.” ”
Find more here.
Stay updated with Hemostasis Today.
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities
-
Feb 22, 2026, 09:12Arun V J։ The Hidden Risks in Every Blood Bag
-
Feb 22, 2026, 08:56Parandzem Khachatryan։ How Hard Is It to Be a Mom, a Wife, a Professor, and a Doctor All at Once?
-
Feb 22, 2026, 08:46Anirban Sen Gupta Presents Bioinspired Platelet Surrogates at MTEC
-
Feb 22, 2026, 08:31Heghine Khachatryan: Advancing Care for Women and Girls with Bleeding Disorders is A Matter of Equity